Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Stimulant Drugs on Social Perception
NCT03790618Phase 1Completed
- Sponsor
- University of Chicago
- Start
- Jun 2016
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of midomafetamine in post-traumatic stress disorder (PTSD) (4 arms), sponsored by University of Chicago. Primary endpoint: Responses to Affective Touch. Started Jun 2016; status: completed.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03790618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03790618.